NICE approves two more treatment options for advanced breast cancer

Off BMJ, British Medical Journal, Obstetrics and gynaecology, Oncology, General practice / family medicine, UK, Science and Health, Science and Research, Uncategorized

The National Institute for Health and Care Excellence (NICE) has recommended two more breast cancer drugs, Piqray and Trodelvy, after reaching agreements with drug companies on price.Alpelisib…

Read Original Article: NICE approves two more treatment options for advanced breast cancer »

About The Author